Grants and Support
Anthony J. Aldave, MD

Ocunexus Therapeutics
Role: Site Principal Investigator
Duration: 10/1/21-9/30/26
Description: A Phase 2, randomized, prospective, double-masked, vehicle-controlled study to assess the efficacy and safety of Nexagon® applied topically in subjects with corneal persistent epithelial defects (PED) resulting from severe ocular chemical and/or thermal injuries.

Oyster Point Pharma, Inc.
Role: Site Principal Investigator
Duration: 8/11/21-8/10/26
Description: A Phase 2, Multicenter, Randomized, Controlled, Double-Masked, Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray in Subjects with Neurotrophic Keratopathy (the Olympia Study

NIH/National Eye Institute
Role: Site Principal Investigator
Duration: 05/01/21-04/30/26
Description: Diabetes Endothelial Keratoplasty Study (DEKS): Impact of Diabetes on Corneal Transplant Success and Cell Loss

Eye Bank Association of America
Role: Principal Investigator
Duration: 07/01/21-06/30/22
Description: EBAA Pilot Research Grant: Does COVID-19 vaccination increase the risk of corneal transplant rejection?

UCLA Faculty Research Grant
Role: Principal Investigator
Duration: 07/01/21-06/30/22
Description: Determining the impact of SLC4A11 deficiency on oxidative stress and assessing the therapeutic effect of SkQ1 treatment in SLC4A11-deficient cell-based models of corneal endothelial dystrophies

UCLA Global Health Seed Grant
Role: Principal Investigator
Duration: 06/01/21-05/31/22
Description: Prospective clinical trial evaluating the usage of sterile preserved cornea tissue in treating infectious corneal perforation in Vietnam
Doug Chung, PhD

Knights Templar Eye Foundation Career Starter Grant
Role: Principal Investigator
Duration: 07/01/21-06/30/22
Description: Elucidating the role of SLC4A11 in Congenital Hereditary Endothelial Dystrophy
Wenlin Zhang, MD, PhD

ARVO Foundation/EBAA EyeFind Research Grant
Role: Principal Investigator
Duration: 07/01/21-06/30/22
Description: Quantitative super-resolution localization of SLC4A11 variants in human corneal endothelium in its native environment